Drug Information

Drug General Information
Drug ID
D03NUC
Former ID
DNC013799
Drug Name
Cyclopentylcarbamic Acid Biphenyl-3-yl Ester
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529498]
Structure
Download
2D MOL

3D MOL
Formula
C18H19NO2
Canonical SMILES
C1CCC(C1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
InChI
1S/C18H19NO2/c20-18(19-16-10-4-5-11-16)21-17-12-6-9-15(13-17)14-7-2-1-3-8-14/h1-3,6-9,12-13,16H,4-5,10-11H2,(H,19,20)
InChIKey
ASBRBCNHGJSXLE-UHFFFAOYSA-N
PubChem Compound ID
24881674
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529498]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
Ref 529498J Med Chem. 2008 Jun 26;51(12):3487-98. Epub 2008 May 29.Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.